Related Experiment Video
Updated: Apr 7, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Post-TAVR Bleeding in Atrial Fibrillation Patients Treated With Apixaban or Rivaroxaban
Olivier Morel1, Antonin Trimaille2, Mickael Guglieri3
1Department of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France; Research Unit 3074 (UR 3074) Translational Cardiovascular Medicine, CRBS, University of Strasbourg, France; GERCA - Groupe pour l'Enseignement, la Prévention et la Recherche Cardiologique en Alsace, Strasbourg, France; Hanoï Medical University, Vietnam.
No abstract available in PubMed .
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

